Since the interaction of cells with fibronectin lead to increased resistance to different cytotoxic drugs (CAM-DR) and MGP augments this interaction, we have formulated a hypothesis that MGP–fibronectin interaction can intensify CAM-DR in cancer cells (Figure 7). This evidence concerns the gene FN1 and cancer.